Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...

Thousands of U.S. Navy service members, veterans, and their beneficiaries who tested positive in a screening typically used for colon cancer were never alerted to the results and few received follow ...

When patients of the Harris Health System have a positive FIT result, they are referred to a gastroenterologist for a colonoscopy. To help patients understand how to properly prepare for the procedure ...

1. A Single Office-Based Stool Blood Test (FOBT) Is a Poor, but Often Used, Screening Test for Colorectal Cancer Two articles and an editorial in the Jan. 18, 2005, Annals of Internal Medicine discuss ...

Analyzing data gathered between 2000 and 2008, researchers observed a significant decline in FOBT prevalence in higher socioeconomic status groups, but not in lower socioeconomic status groups. During ...

Squamous Cell Carcinoma of the Anus Incidence, Mortality, and Survival Among the General Population and Persons Living With HIV in Puerto Rico, 2000-2016 The median age of participants was 61 years ...

Occult blood refers to small traces of blood that a person cannot see in their stool. The presence of blood in the stool could be a sign of an underlying condition. Health experts often use this test ...

TO THE EDITORS:In the July issue of The American Journal of Managed Care, Schroy et al 1 reported on preferences for colorectal cancer (CRC) screening tests in relation to currently recommended ...

Although European controlled trials of screening with a nonrehydrated guaiac-based fecal occult blood test (gFOBT) have shown it reduces colorectal cancer (CRC) deaths, real-world results could differ ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

When given a choice, most individuals with an average risk of colorectal cancer said they would prefer a stool-based screening test for colorectal cancer over colonoscopy, the method most often ...